Strides to exit investment in Arrow for AUD 394 million

In a separate filing, the company said its step-down subsidiary Strides Pharma Inc has entered into an arrangement to acquire 100 per cent stake in US-based generics company Vensun Pharmaceuticals Inc.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2RUthQo
via IFTTT